The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Updates to the 2017 guideline focus on new monitoring strategies, earlier intervention to reduce cognitive decline, improved perinatal care, and refined risk assessment.

Sydney Jennings

August 7th 2025

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NHIS Data Brief / image credit ©Sebastian Garcia/stock.adobe.com

Make It Routine: Screening for Cognitive Decline in Primary Care

GLP-1 use among adults with diabetes peaked among those aged 50 to 64 years, was highest among Hispanic adults, and was more likely among those taking other antihyperglycemic agents.

Anna Chodos, MD, MPH;Sydney Jennings

July 24th 2025

Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Amesh Adalja, MD;Sydney Jennings

Initial RSV Vaccine Uptake Low Among Older Adults, Disparities Persist, Study Reveals

Infectious disease expert Amesh Adalja, MD, discusses key vaccine policy changes, strategies to combat misinformation, and ways PCPs can boost vaccine confidence.

AHA/ACC Release Revised Hypertension Clinical Practice Guidelines to Reduce CVD Risk

Fewer than 1 in 5 eligible older adults in the US received the RSV vaccine during the first 2 seasons it was available, and uptake was lower based on SDOH.

Related Content

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Updates to the 2017 guideline focus on new monitoring strategies, earlier intervention to reduce cognitive decline, improved perinatal care, and refined risk assessment.

Sydney Jennings

August 7th 2025

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Make It Routine: Screening for Cognitive Decline in Primary Care

GLP-1 use among adults with diabetes peaked among those aged 50 to 64 years, was highest among Hispanic adults, and was more likely among those taking other antihyperglycemic agents.

Anna Chodos, MD, MPH;Sydney Jennings

July 24th 2025

Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Amesh Adalja, MD;Sydney Jennings

Initial RSV Vaccine Uptake Low Among Older Adults, Disparities Persist, Study Reveals

Infectious disease expert Amesh Adalja, MD, discusses key vaccine policy changes, strategies to combat misinformation, and ways PCPs can boost vaccine confidence.